John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
American International
AIG
$39.9B
| $398K | ﹤0.01% |
10,509
| – | – |
|
2652
PUT
Brighthouse Financial
BHF
$2.98B
| $398K | ﹤0.01% |
+11,000
| New | +$369K |
|
2653
CALL
International Paper
IP
$21.7B
| $398K | ﹤0.01% |
8,448
+1,162
| +16% | +$52K |
|
2654
PUT
Wingstop
WING
$3.1B
| $398K | ﹤0.01% |
3,000
-16,300
| -84% | -$2.13M |
|
2655
CALL
HealthEquity
HQY
$8.81B
| $397K | ﹤0.01% |
+5,700
| New | +$355K |
|
2656
CALL
Principal Financial Group
PFG
$23.9B
| $397K | ﹤0.01% |
8,000
+1,400
| +21% | +$64.1K |
|
2657
CALL
W.P. Carey
WPC
$16.4B
| $395K | ﹤0.01% |
+5,718
| New | +$382K |
|
2658
InMode
INMD
$865M
| $394K | ﹤0.01% |
16,600
-2,400
| -13% | -$50.7K |
|
2659
PUT
PBF Energy
PBF
$7.88B
| $393K | ﹤0.01% |
55,400
+37,000
| +201% | +$241K |
|
2660
CALL
Iron Mountain
IRM
$36B
| $392K | ﹤0.01% |
13,300
+300
| +2% | +$8.32K |
|
2661
CALL
Pinnacle West Capital
PNW
$11.8B
| $392K | ﹤0.01% |
+4,900
| New | +$404K |
|
2662
Saratoga Investment
SAR
$296M
| $392K | ﹤0.01% |
18,805
-5,947
| -24% | -$119K |
|
|
ACGN
2663
DELISTED
Aceragen Inc
ACGN
| $392K | ﹤0.01% |
+6,296
| New | +$361K |
|
2664
Cars.com
CARS
$661M
| $391K | ﹤0.01% |
34,576
-12,708
| -27% | -$127K |
|
2665
AngioDynamics
ANGO
$659M
| $390K | ﹤0.01% |
25,408
-96,157
| -79% | -$1.22M |
|
2666
CALL
Churchill Downs
CHDN
$6.18B
| $390K | ﹤0.01% |
4,000
+800
| +25% | +$72.7K |
|
2667
Encore Capital Group
ECPG
$2.17B
| $390K | ﹤0.01% |
+10,015
| New | +$364K |
|
2668
Kamada
KMDA
$498M
| $390K | ﹤0.01% |
+60,157
| New | +$428K |
|
2669
CALL
Ubiquiti
UI
$34.9B
| $390K | ﹤0.01% |
+1,400
| New | +$322K |
|
|
FLY
2670
DELISTED
Fly Leasing Limited
FLY
| $390K | ﹤0.01% |
+39,636
| New | +$309K |
|
2671
CALL
Ameriprise Financial
AMP
$49.5B
| $389K | ﹤0.01% |
+2,000
| New | +$358K |
|
|
DFS
2672
PUT
DELISTED
Discover Financial Services
DFS
| $389K | ﹤0.01% |
4,300
-11,800
| -73% | -$880K |
|
|
XIFR
2673
CALL
XPLR Infrastructure LP
XIFR
$1.1B
| $389K | ﹤0.01% |
+5,800
| New | +$374K |
|
2674
PUT
Welltower
WELL
$174B
| $388K | ﹤0.01% |
+6,000
| New | +$364K |
|
|
KSU
2675
PUT
DELISTED
Kansas City Southern
KSU
| $388K | ﹤0.01% |
1,900
+400
| +27% | +$75.1K |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.